{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:06:43Z","timestamp":1762639603394,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031022","name":"Center for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Bristol-Myers Squibb Co","doi-asserted-by":"publisher","award":["02328"],"award-info":[{"award-number":["02328"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jtct.2025.02.023","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:20:14Z","timestamp":1741144814000},"page":"361.e1-361.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft Versus Host Disease: A Randomized Clinical Study"],"prefix":"10.1016","volume":"31","author":[{"given":"Jessica J.","family":"Jorgensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galen O.","family":"Joe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Jim\u00e9nez-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Shu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiara","family":"Dunigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9774-7322","authenticated-orcid":false,"given":"Leora E.","family":"Comis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtct.2025.02.023_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"7","key":"10.1016\/j.jtct.2025.02.023_bib0002","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood.2020006892","article-title":"A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease","volume":"18","author":"Curtis","year":"2021","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jtct.2025.02.023_bib0003","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"8","key":"10.1016\/j.jtct.2025.02.023_bib0004","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1182\/blood-2006-02-003954","article-title":"Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study","volume":"108","author":"Fraser","year":"2006","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.jtct.2025.02.023_bib0005","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1182\/blood-2010-11-319509","article-title":"Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium","volume":"117","author":"Pidala","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.02.023_bib0006","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.023_bib0007","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.3324\/haematol.2018.192930","article-title":"Patient-reported outcomes and health status associated with chronic graft-versus-host disease","volume":"103","author":"Lee","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.023_bib0008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0277-9536(91)90149-7","article-title":"Role retention and quality of life of bone marrow transplant survivors","volume":"32","author":"Baker","year":"1991","journal-title":"Soc Sci Med"},{"issue":"1","key":"10.1016\/j.jtct.2025.02.023_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1188\/11.ONF.75-83","article-title":"A pilot study of activity engagement in the first six months after stem cell transplantation","volume":"38","author":"Lyons","year":"2011","journal-title":"Oncol Nurs Forum"},{"issue":"30","key":"10.1016\/j.jtct.2025.02.023_bib0010","doi-asserted-by":"crossref","first-page":"5008","DOI":"10.1200\/JCO.2009.23.6802","article-title":"Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma","volume":"27","author":"Lacy","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.023_bib0011","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.bbmt.2015.02.025","article-title":"Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report","volume":"21","author":"Lee","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.023_bib0012","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.023_bib0013","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","article-title":"Chronic graft-versus-host disease","volume":"9","author":"Lee","year":"2003","journal-title":"Biol Blood Marrow Transplantation"},{"year":"2008","author":"Baum","series-title":"Activity Card Sort (ACS)","key":"10.1016\/j.jtct.2025.02.023_bib0014"},{"issue":"1","key":"10.1016\/j.jtct.2025.02.023_bib0015","first-page":"10","article-title":"Participation in occupational performance: reliability and validity of the activity card sort","volume":"23","author":"Katz","year":"2003","journal-title":"OTJR"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.023_bib0016","doi-asserted-by":"crossref","first-page":"562","DOI":"10.5014\/ajot.2010.09033","article-title":"Consistency and construct validity of the Activity Card Sort (modified) in measuring activity resumption after stem cell transplantation","volume":"64","author":"Lyons","year":"2010","journal-title":"Am J Occup Ther"},{"issue":"1","key":"10.1016\/j.jtct.2025.02.023_bib0017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2519\/jospt.2014.4893","article-title":"Minimal clinically important difference of the disabilities of the arm, shoulder and hand outcome measure (DASH) and its shortened version (QuickDASH)","volume":"44","author":"Franchignoni","year":"2014","journal-title":"J Orthop Sports Phys Ther"},{"year":"2011","author":"Kennedy","series-title":"DASH and QuickDASH Outcome Measure User's Manual Third ed","key":"10.1016\/j.jtct.2025.02.023_bib0018"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.023_bib0019","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.apmr.2009.11.012","article-title":"Psychometric validation of the Manual Ability Measure-36 (MAM-36) in patients with neurologic and musculoskeletal disorders","volume":"91","author":"Chen","year":"2010","journal-title":"Arch Phy Med Rehab"},{"issue":"2","key":"10.1016\/j.jtct.2025.02.023_bib0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5014\/ajot.2014.009258","article-title":"Responsiveness of the manual ability measure\u201436 (MAM\u201336): changes in hand function using self-reported and clinician-rated assessments","volume":"68","author":"Chen","year":"2014","journal-title":"Am J Occup Ther"},{"issue":"10","key":"10.1016\/j.jtct.2025.02.023_bib0021","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1182\/blood-2011-04-314815","article-title":"How I conduct a comprehensive chronic graft-versus-host disease assessment","volume":"118","author":"Carpenter","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.023_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.bbmt.2006.01.008","article-title":"Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report","volume":"12","author":"Pavletic","year":"2006","journal-title":"Biol Blood Marrow Transplantation"},{"year":"1965","author":"Jackson","series-title":"Joint Motion\u202f: Method of Measuring and Recording \/ [Prepared and Submitted by Members of the Committee for the Study of Joint Motion]","key":"10.1016\/j.jtct.2025.02.023_bib0023"},{"year":"2016","author":"Norkin","series-title":"Measurement of Joint Motion: A Guide to Goniometry","key":"10.1016\/j.jtct.2025.02.023_bib0024"},{"key":"10.1016\/j.jtct.2025.02.023_bib0025","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2147\/COPD.S143179","article-title":"Minimal important difference and responsiveness of 2-minute walk test performance in people with COPD undergoing pulmonary rehabilitation","volume":"12","author":"Johnston","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"10.1016\/j.jtct.2025.02.023_bib0026","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jor.1100060208","article-title":"Energy-speed relationship of walking: Standard tables","volume":"6","author":"Waters","year":"1988","journal-title":"J Orthop Res"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.023_bib0027","first-page":"1727","article-title":"A hospital and home-based exercise program to address functional decline in people following allogeneic stem cell transplantation","volume":"26","author":"Abo","year":"2018","journal-title":"Support Care Cancer"},{"issue":"3","key":"10.1016\/j.jtct.2025.02.023_bib0028","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1016\/j.bbmt.2018.12.272","article-title":"Using functional performance measures to assess clinical response in patients with sclerotic chronic graft versus host disease: an exploratory study","volume":"25","author":"Rosenthal","year":"2019","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"12","key":"10.1016\/j.jtct.2025.02.023_bib0029","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bbmt.2010.05.018","article-title":"Validation of the Human Activity Profile Questionnaire in patients after allogeneic hematopoietic stem cell transplantation","volume":"16","author":"Herzberg","year":"2010","journal-title":"Biol Blood Marrow Transplantation"},{"year":"1988","author":"Fix","series-title":"Human Activity Profile Professional Manual","key":"10.1016\/j.jtct.2025.02.023_bib0030"},{"issue":"5","key":"10.1016\/j.jtct.2025.02.023_bib0031","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.21455","article-title":"Evaluation of the human activity profile for use with persons with arthritis","volume":"53","author":"Bilek","year":"2005","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.jtct.2025.02.023_bib0032","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7525-9-24","article-title":"Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol","volume":"9","author":"Bevans","year":"2011","journal-title":"Health Quality of Life Outcomes"},{"issue":"4","key":"10.1016\/j.jtct.2025.02.023_bib0033","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/bmt.2009.238","article-title":"Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)","volume":"45","author":"Mitchell","year":"2010","journal-title":"Bone Marrow Transplantation"},{"year":"2011","author":"Maruish","series-title":"User\u2019s Manual for the SF-36v2 Health Survey","key":"10.1016\/j.jtct.2025.02.023_bib0034"},{"issue":"10","key":"10.1016\/j.jtct.2025.02.023_bib0035","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bbmt.2012.05.016","article-title":"Clinical benefit of response in chronic graft-versus-host disease","volume":"18","author":"Inamoto","year":"2012","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"5","key":"10.1016\/j.jtct.2025.02.023_bib0036","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.bbmt.2020.01.022","article-title":"A systematic review of patient reported outcome measures in graft-versus-host-disease (GVHD)","volume":"26","author":"Kilgour","year":"2020","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"6","key":"10.1016\/j.jtct.2025.02.023_bib0037","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbmt.2015.03.006","article-title":"Imatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease","volume":"21","author":"Baird","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. In: Computing RFfS, editor. Vienna, Austria 2024.","key":"10.1016\/j.jtct.2025.02.023_bib0038"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.023_bib0039","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2015.137","article-title":"Patient-reported quality of life after allogeneic hematopoietic cell transplantation or chemotherapy for acute leukemia","volume":"50","author":"Kurosawa","year":"2015","journal-title":"Bone Marrow Transplantation"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.023_bib0040","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bbmt.2019.05.016","article-title":"Resolved versus active chronic graft-versus-host disease: impact on post-transplantation quality of life","volume":"25","author":"Kurosawa","year":"2019","journal-title":"Biol Blood Marrow Transplantation"},{"issue":"9","key":"10.1016\/j.jtct.2025.02.023_bib0041","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1002\/art.38697","article-title":"Prevalence of isolated joint involvement in chronic graft-versus-host disease: comment on the article by Inamoto et al","volume":"66","author":"Kuzmina","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T22:02:27Z","timestamp":1762639347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725010590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666636725010590"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.023","relation":{},"ISSN":["2666-6367"],"issn-type":[{"type":"print","value":"2666-6367"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft Versus Host Disease: A Randomized Clinical Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}